Transforming Growth Factor β1 Signaling via Interaction with Cell Surface Hyal-2 and Recruitment of WWOX/WOX1*

Transforming growth factor β (TGF-β) initiates multiple signal pathways and activates many downstream kinases. Here, we determined that TGF-β1 bound cell surface hyaluronidase Hyal-2 on microvilli in type II TGF-β receptor-deficient HCT116 cells, as determined by immunoelectron microscopy. This binding resulted in recruitment of proapoptotic WOX1 (also named WWOX or FOR) and formation of Hyal-2·WOX1 complexes for relocation to the nuclei. TGF-β1 strengthened the binding of the catalytic domain of Hyal-2 with the N-terminal Tyr-33-phosphorylated WW domain of WOX1, as determined by time lapse fluorescence resonance energy transfer analysis in live cells, co-immunoprecipitation, and yeast two-hybrid domain/domain mapping. In promoter activation assay, ectopic WOX1 or Hyal-2 alone increased the promoter activity driven by Smad. In combination, WOX1 and Hyal-2 dramatically enhanced the promoter activation (8–9-fold increases), which subsequently led to cell death (>95% of promoter-activated cells). TGF-β1 supports L929 fibroblast growth. In contrast, transiently overexpressed WOX1 and Hyal-2 sensitized L929 to TGF-β1-induced apoptosis. Together, TGF-β1 invokes a novel signaling by engaging cell surface Hyal-2 and recruiting WOX1 for regulating the activation of Smad-driven promoter, thereby controlling cell growth and death.

[1]  G. Stein,et al.  Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis. , 2009, Endocrinology.

[2]  Stefano Volinia,et al.  The WWOX Tumor Suppressor Is Essential for Postnatal Survival and Normal Bone Metabolism* , 2008, Journal of Biological Chemistry.

[3]  R. Baron,et al.  p53 Brings a New Twist to the Smad Signaling Network , 2008, Science Signaling.

[4]  L. Hsu,et al.  MPP+‐induced neuronal death in rats involves tyrosine 33 phosphorylation of WW domain‐containing oxidoreductase WOX1 , 2008, The European journal of neuroscience.

[5]  L. Hsu,et al.  Zfra is an inhibitor of Bcl‐2 expression and cytochrome c release from the mitochondria , 2008, Cellular signalling.

[6]  J. Ludes-Meyers,et al.  WWOX hypomorphic mice display a higher incidence of B‐cell lymphomas and develop testicular atrophy , 2007, Genes, chromosomes & cancer.

[7]  Bernhard Schmierer,et al.  TGFβ–SMAD signal transduction: molecular specificity and functional flexibility , 2007, Nature Reviews Molecular Cell Biology.

[8]  C. Croce,et al.  Association of Wwox with ErbB4 in breast cancer. , 2007, Cancer research.

[9]  D. Iliopoulos,et al.  Wwox Suppresses Prostate Cancer Cell Growth through Modulation of ErbB2-Mediated Androgen Receptor Signaling , 2007, Molecular Cancer Research.

[10]  C. Croce,et al.  WWOX in biological control and tumorigenesis , 2007, Journal of cellular physiology.

[11]  F. Giancotti,et al.  Shedding light on Merlin's wizardry. , 2007, Trends in cell biology.

[12]  G. Stein,et al.  Targeted deletion of Wwox reveals a tumor suppressor function , 2007, Proceedings of the National Academy of Sciences.

[13]  David I. Smith,et al.  Large common fragile site genes and cancer. , 2007, Seminars in cancer biology.

[14]  L. Hsu,et al.  WW domain-containing oxidoreductase: a candidate tumor suppressor. , 2007, Trends in molecular medicine.

[15]  Q. Hong,et al.  Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-κB, JNK1, p53 and WOX1 during stress response , 2007, BMC Molecular Biology.

[16]  D. Iliopoulos,et al.  A role for the WWOX gene in prostate cancer. , 2006, Cancer research.

[17]  Xia Ding,et al.  PKA-mediated protein phosphorylation regulates ezrin-WWOX interaction. , 2006, Biochemical and biophysical research communications.

[18]  A. Bednarek,et al.  WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[19]  M. J. Jedrzejas,et al.  Hyaluronidases: their genomics, structures, and mechanisms of action. , 2006, Chemical reviews.

[20]  L. Hsu,et al.  Light-induced retinal damage involves tyrosine 33 phosphorylation, mitochondrial and nuclear translocation of WW domain-containing oxidoreductase in vivo , 2005, Neuroscience.

[21]  Q. Hong,et al.  WOX1 Is Essential for Tumor Necrosis Factor-, UV Light-, Staurosporine-, and p53-mediated Cell Death, and Its Tyrosine 33-phosphorylated Form Binds and Stabilizes Serine 46-phosphorylated p53* , 2005, Journal of Biological Chemistry.

[22]  James L Mohler,et al.  Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox. , 2005, Cancer research.

[23]  S. Nilsson,et al.  The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer. , 2005, Experimental cell research.

[24]  D. Amadori,et al.  WWOX gene restoration prevents lung cancer growth in vitro and in vivo , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Sabrina Cattaruzza,et al.  Proteoglycan control of cell movement during wound healing and cancer spreading. , 2005, Matrix biology : journal of the International Society for Matrix Biology.

[26]  V. Lokeshwar,et al.  HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor. , 2005, Cancer research.

[27]  L. Hsu,et al.  WOX1 Is Essential for UVB Irradiation–Induced Apoptosis and Down-Regulated via Translational Blockade in UVB-Induced Cutaneous Squamous Cell Carcinoma In vivo , 2005, Clinical Cancer Research.

[28]  Y. Pekarsky,et al.  WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. , 2005, Cancer research.

[29]  V. Lokeshwar,et al.  HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion. , 2005, Cancer research.

[30]  L. Hsu,et al.  17β-Estradiol upregulates and activates WOX1/WWOXv1 and WOX2/WWOXv2 in vitro: potential role in cancerous progression of breast and prostate to a premetastatic state in vivo , 2005, Oncogene.

[31]  B. Park,et al.  Duel nature of TGF-β signaling: tumor suppressor vs. tumor promoter , 2005 .

[32]  J. Chuang,et al.  Expression of WW domain-containing oxidoreductase WOX1 in the developing murine nervous system , 2004, Neuroscience.

[33]  R. Weigel,et al.  Physical and Functional Interactions between the Wwox Tumor Suppressor Protein and the AP-2γ Transcription Factor , 2004, Cancer Research.

[34]  N. Sergina,et al.  Autocrine and Exogenous Transforming Growth Factor β Control Cell Cycle Inhibition through Pathways with Different Sensitivity* , 2004, Journal of Biological Chemistry.

[35]  J. Heath,et al.  Down-regulation of WW Domain-containing Oxidoreductase Induces Tau Phosphorylation in Vitro , 2004, Journal of Biological Chemistry.

[36]  Nan-Shan Chang,et al.  TIAF1 and p53 functionally interact in mediating apoptosis and silencing of TIAF1 abolishes nuclear translocation of serine 15-phosphorylated p53. , 2004, DNA and cell biology.

[37]  A. Phillips,et al.  Hyaluronan attenuates transforming growth factor-beta1-mediated signaling in renal proximal tubular epithelial cells. , 2004, The American journal of pathology.

[38]  D. Iliopoulos,et al.  The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma , 2004, Cancer.

[39]  Y. Pekarsky,et al.  Functional association between Wwox tumor suppressor protein and p73, a p53 homolog. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[40]  H. Aburatani,et al.  An opposing view on WWOX protein function as a tumor suppressor. , 2003, Cancer research.

[41]  S. Dupont,et al.  Links between Tumor Suppressors p53 Is Required for TGF-β Gene Responses by Cooperating with Smads , 2003, Cell.

[42]  N. Chang,et al.  JNK1 Physically Interacts with WW Domain-containing Oxidoreductase (WOX1) and Inhibits WOX1-mediated Apoptosis* , 2003, The Journal of Biological Chemistry.

[43]  L. Bourguignon,et al.  Hyaluronan Promotes Signaling Interaction between CD44 and the Transforming Growth Factor β Receptor I in Metastatic Breast Tumor Cells* , 2002, The Journal of Biological Chemistry.

[44]  N. Chang Transforming growth factor-β1 blocks the enhancement of tumor necrosis factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts , 2002, BMC Cell Biology.

[45]  N. Chang The Non-ankyrin C Terminus of IκBα Physically Interacts with p53 in Vivo and Dissociates in Response to Apoptotic Stress, Hypoxia, DNA Damage, and Transforming Growth Factor-β1-mediated Growth Suppression* , 2002, The Journal of Biological Chemistry.

[46]  H. Prydz,et al.  Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors , 2002, Oncogene.

[47]  Marius Sudol,et al.  The WW domain: linking cell signalling to the membrane cytoskeleton. , 2002, Cellular signalling.

[48]  A. Brenner,et al.  WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. , 2001, Cancer research.

[49]  Y. H. Chang,et al.  Alteration of Bcl-2 expression in the nigrostriatal system after kainate injection with or without melatonin co-treatment , 2001, Journal of Chemical Neuroanatomy.

[50]  F. Duh,et al.  Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Heath,et al.  Hyaluronidase Induction of a WW Domain-containing Oxidoreductase That Enhances Tumor Necrosis Factor Cytotoxicity* , 2001, The Journal of Biological Chemistry.

[52]  R. Richards,et al.  Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. , 2000, Human molecular genetics.

[53]  N. Chang Transforming growth factor-beta protection of cancer cells against tumor necrosis factor cytotoxicity is counteracted by hyaluronidase (review). , 1998, International journal of molecular medicine.

[54]  G. Kreil,et al.  HYAL2, a Human Gene Expressed in Many Cells, Encodes a Lysosomal Hyaluronidase with a Novel Type of Specificity* , 1998, The Journal of Biological Chemistry.

[55]  M. Brattain,et al.  Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells. , 1997, Biochemistry.

[56]  N. Chang Hyaluronidase enhancement of TNF-mediated cell death is reversed by TGF-beta 1. , 1997, The American journal of physiology.

[57]  P. Bork,et al.  Characterization of a novel protein‐binding module — the WW domain , 1995, FEBS letters.